INVA · Innoviva, Inc.
AI read · Good for INVA
The AI's read
The rating gives investors a favorable new outside view of Innoviva. It does not report a change in sales, profits, or operations, so the support comes from the analyst's view alone.
Piper Sandler began covering Innoviva, gave it an Overweight rating, and set a $29 target. This is a favorable analyst view, though it reports no change in Innoviva's business results.
The rating gives investors a favorable new outside view of Innoviva. It does not report a change in sales, profits, or operations, so the support comes from the analyst's view alone.
Follow Innoviva, Inc. (INVA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for INVA